MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
RAPP Rapport Therapeutics
- 18.070
- +0.210+1.18%
Close Dec 20 16:00 ET
- 17.900
- -0.170-0.94%
Post 20:01 ET
660.94MMarket Cap-9.20P/E (TTM)
19.085High17.520Low527.56KVolume17.570Open17.860Pre Close9.55MTurnover5.73%Turnover RatioLossP/E (Static)36.58MShares29.74052wk High2.05P/B166.24MFloat Cap16.55052wk Low--Dividend TTM9.20MShs Float29.740Historical High--Div YieldTTM8.76%Amplitude16.550Historical Low18.094Avg Price1Lot Size
Rapport Therapeutics News
Rapport Therapeutics | 8-K: Current report
Rapport Therapeutics | 8-K: Current report
Rapport Therapeutics | 8-K: Current report
Rapport Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Rapport Therapeutics, Inc. | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Rapport Therapeutics, Inc. | S-1: General form for registration of securities under the Securities Act of 1933
No More
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.